Related Experiment Videos
Lymphangiogenesis and tumour metastasis
Jean-Christophe Tille1, Riccardo Nisato, Michael S Pepper
1Department of Morphology, University Medical Center, 1 rue Michel Servet, 1211 Geneva 4, Switzerland.
Novartis Foundation Symposium
|March 19, 2004
Summary
Vascular Endothelial Growth Factor-C (VEGF-C) promotes tumor spread to lymph nodes. While animal models show VEGF-C causes new lymphatic vessel growth, in humans, it may activate existing lymphatics for tumor cell metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The lymphatic system is crucial for immune response and fluid balance.
- Tumor metastasis often utilizes the lymphatic system for dissemination.
- Vascular Endothelial Growth Factor-C (VEGF-C) is implicated in cancer progression.
Purpose of the Study:
- To investigate the role of VEGF-C in human tumor metastasis.
- To explore the mechanisms by which VEGF-C contributes to lymph node metastasis.
Main Methods:
- Analysis of VEGF-C expression in primary human tumors.
- Correlation studies between VEGF-C levels and lymph node metastasis.
- Review of experimental data from animal models (transgenic mice, xenotransplantation).
Main Results:
- Increased VEGF-C expression in primary tumors correlates with lymph node metastasis in humans.
- Animal studies demonstrate VEGF-C induces tumor lymphangiogenesis and metastasis.
- Limited evidence for lymphangiogenesis in human tumors contrasts with animal models.
Conclusions:
- VEGF-C plays a significant role in human tumor metastasis to lymph nodes.
- VEGF-C may activate pre-existing lymphatic vessels, facilitating tumor cell transport.
- The precise role of VEGF-C in human lymphangiogenesis requires further investigation.